Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.
Primaquine is the only available antimalarial drug that kills dormant liver stages of Plasmodium vivax and Plasmodium ovale malarias and therefore prevents their relapse ('radical cure'). It is also the only generally available antimalarial that rapidly sterilises mature P. falciparum game...
Saved in:
Main Authors: | Judith Recht (Author), Elizabeth A Ashley (Author), Nicholas J White (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Weekly primaquine for radical cure of patients with Plasmodium vivax malaria and glucose-6-phosphate dehydrogenase deficiency.
by: Walter R J Taylor, et al.
Published: (2023) -
Prevalence of glucose-6-phosphate dehydrogenase deficiency (G6PDd) and clinical implication for safe use of primaquine in malaria-endemic areas of Hainan Province, China
by: Wen Zeng, et al.
Published: (2022) -
Glucose-6-phosphate dehydrogenase deficiency and the use of primaquine: top-down and bottom-up estimation of professional costs
by: Henry Maia Peixoto, et al.
Published: (2017) -
Prevalence of glucose 6-phosphate dehydrogenase deficiency in highly malaria-endemic municipalities in the Brazilian Amazon: A region-wide screening study
by: Joabi Rocha Nascimento, et al.
Published: (2022) -
Glucose-6-phosphate Dehydrogenase Deficiency: A Review
by: Nidhruv Ravikumar, et al.
Published: (2020)